近視・老眼治療市場：治療法別、適応症別-2025-2030年の世界予測

近視・老眼治療市場は、2023年に194億7,000万米ドルと評価され、2024年には209億米ドルに達すると予測され、CAGR 7.84％で成長し、2030年には330億4,000万米ドルに達すると予測されています。

近視・老眼治療市場には、これらの一般的な視力障害の矯正を目的としたさまざまな製品とサービスが含まれます。近視（近視症）と老視（加齢に伴う遠視症）には、眼鏡、コンタクトレンズ、外科的解決策、新たな薬理学的アプローチなど、異なるが時に重複する治療が必要です。これらの治療が必要とされる背景には、人口の高齢化や若年層におけるスクリーン使用時間の長さなどの要因により、視覚障害の有病率が増加していることがあります。用途は、矯正眼鏡、屈折矯正手術、オルソKレンズやアトロピン点眼薬などの革新的な介入に及んでいます。最終用途分野には、検眼クリニック、病院、専門眼科医療センター、オンライン小売プラットフォームなどがあります。

主な成長要因としては、レンズ素材や手術技術の技術的進歩、目の健康に対する意識の高まり、新興市場における治療費の値ごろ感などが挙げられます。バーチャル試着技術や遠隔医療サービスのような、非侵襲的治療やデジタルソリューションの開発には豊富な機会があります。企業は、AIを活用した診断やオーダーメイドのソリューションを活用した個別化治療計画に注力すべきです。ハイテク企業とのコラボレーションは、デジタル眼精疲労を軽減するように設計されたスマートアイウェアの成長を促進する可能性もあります。

しかし、市場の成長は、高度な手術オプションの高額な費用、規制上の課題、低コストの代替品の普及といった限界に直面しています。競合からの圧力や治療の複雑さも課題となっています。技術革新の主な分野には、持続可能な生分解性レンズ素材の開発、高度な反射防止コーティング、薬理学的治療のさらなる探求などがあります。小児の近視予防や、ライフスタイル要因と老眼進行の関連性についての研究は、製品開発の新たな道を開く可能性があります。

全体として、市場は急速な技術進化と競合情勢を特徴としています。一歩先を行くには、継続的な技術革新、戦略的パートナーシップ、消費者動向や規制の変化への対応が必要です。企業は、成長を促進し、世界市場の進化する需要に対応するために、患者の体験、手頃な価格、環境の持続可能性を高めることに注力すべきです。

市場力学：急速に進化する近視・老眼治療市場の主要市場インサイトを公開

近視・老眼治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 視力障害の有病率の増加
  • 老年人口の増加
  • 老眼矯正のための低侵襲な代替手段
• 市場抑制要因
  • 早期診断の欠如と製品リコール
• 市場機会
  • 市場合併の活発化
  • インプラントコンタクトレンズなどの高度なレンズのイントロダクションよる新たな発展
• 市場の課題
  • 治療に伴う高コスト

ポーターの5つの力：近視・老眼治療市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：近視・老眼治療市場における外部からの影響の把握

外部マクロ環境要因は、近視・老眼治療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析近視・老眼治療市場における競合情勢の把握

近視・老眼治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス近視・老眼治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、近視・老眼治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨近視・老眼治療市場における成功への道筋を描く

近視・老眼治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 視覚障害の増加
    • 高齢化人口の増加
    • 老眼矯正のための低侵襲代替法
  • 抑制要因
    • 早期診断と製品リコールの欠如
  • 機会
    • 市場統合活動の増加
    • インプラントコンタクトレンズなどの先進レンズのイントロダクションよる新たな発展
  • 課題
    • 治療にかかる高額な費用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 近視・老眼治療市場治療別

• コンタクトレンズ
• 薬物治療
• 処方レンズ
• 手術

第7章 近視・老眼治療市場適応症別

• 近視
• 老眼

第8章 南北アメリカの近視・老眼治療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の近視・老眼治療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの近視・老眼治療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• ABB Optical Group
• AbbVie Inc.
• Accu-Lens Inc.
• Alcon Vision LLC
• Arctic Vision
• Bausch & Lomb Incorporated by Bausch Health Companies Inc.
• Carl Zeiss AG
• CooperVision, Inc.
• Essilor Group
• Euclid Systems Corporation
• Eyenovia, Inc.
• Haag-Streit Group
• Johnson & Johnson Vision
• Menicon Co., Ltd.
• Nidek Co. Ltd.
• Topcon Corporation
• Tylock-George Eye Care & Laser Center
• Ziemer Ophthalmic Systems AG

LIST OF FIGURES

• FIGURE 1. MYOPIA & PRESBYOPIA TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. MYOPIA & PRESBYOPIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. MYOPIA & PRESBYOPIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MYOPIA & PRESBYOPIA TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MYOPIA & PRESBYOPIA TREATMENT MARKET DYNAMICS
• TABLE 7. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CONTACT LENSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY PRESCRIPTION LENSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY MYOPIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY PRESBYOPIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 22. CANADA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 23. CANADA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 34. CHINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 35. CHINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 36. INDIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 37. INDIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 71. ITALY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 72. ITALY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 79. POLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 80. POLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 81. QATAR MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 82. QATAR MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. MYOPIA & PRESBYOPIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 102. MYOPIA & PRESBYOPIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

The Myopia & Presbyopia Treatment Market was valued at USD 19.47 billion in 2023, expected to reach USD 20.90 billion in 2024, and is projected to grow at a CAGR of 7.84%, to USD 33.04 billion by 2030.

The market for myopia and presbyopia treatments encompasses a range of products and services aimed at correcting these common vision impairments. Myopia (nearsightedness) and presbyopia (age-related farsightedness) require different but sometimes overlapping treatments, including glasses, contact lenses, surgical solutions, and emerging pharmacological approaches. The necessity of these treatments is driven by the increasing prevalence of visual impairments due to factors like aging populations and high screen time among younger demographics. Applications span corrective eyewear, refractive surgery, and innovative interventions such as ortho-k lenses and atropine drops. End-use sectors include optometry clinics, hospitals, specialized eye care centers, and online retail platforms.

Key growth factors include technological advancements in lens materials and surgical techniques, heightened awareness of eye health, and increased affordability of treatments across emerging markets. Opportunities are abundant in the development of non-invasive treatments and digital solutions, like virtual try-on technologies and telehealth services. Companies should focus on personalized treatment plans leveraging AI for diagnosis and tailored solutions. Collaborations with tech firms could also drive growth in smart eyewear designed to reduce digital eye strain.

However, market growth faces limitations such as high costs of advanced surgical options, regulatory challenges, and the widespread availability of low-cost alternatives. Competitive pressures and the complexity of certain treatments also pose challenges. Key areas for innovation include the development of sustainable and biodegradable lens materials, advanced anti-reflective coatings, and further exploration of pharmacological treatments. Research into myopia prevention in children and the link between lifestyle factors and presbyopia progression could unlock new avenues for product development.

Overall, the market is characterized by rapid technological evolution and a competitive landscape. Staying ahead requires continuous innovation, strategic partnerships, and responsiveness to consumer trends and regulatory shifts. Businesses should focus on enhancing patient experiences, affordability, and environmental sustainability to drive growth and meet the evolving demands of a global market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Myopia & Presbyopia Treatment Market

The Myopia & Presbyopia Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing Prevalence of Vision Impairment
  • Rising Geriatric Population
  • Minimally Invasive Alternative for Presbyopia Correction
• Market Restraints
  • Lack of Early Diagnosis and Product Recalls
• Market Opportunities
  • Increasing Market Amalgamation Activity
  • Emerging Developments with Introduction of Advanced Lenses such as Implantable Contact Lenses
• Market Challenges
  • High Cost Associated with the Treatment

Porter's Five Forces: A Strategic Tool for Navigating the Myopia & Presbyopia Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Myopia & Presbyopia Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Myopia & Presbyopia Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Myopia & Presbyopia Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Myopia & Presbyopia Treatment Market

A detailed market share analysis in the Myopia & Presbyopia Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Myopia & Presbyopia Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Myopia & Presbyopia Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Myopia & Presbyopia Treatment Market

A strategic analysis of the Myopia & Presbyopia Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Myopia & Presbyopia Treatment Market, highlighting leading vendors and their innovative profiles. These include ABB Optical Group, AbbVie Inc., Accu-Lens Inc., Alcon Vision LLC, Arctic Vision, Bausch & Lomb Incorporated by Bausch Health Companies Inc., Carl Zeiss AG, CooperVision, Inc., Essilor Group, Euclid Systems Corporation, Eyenovia, Inc., Haag-Streit Group, Johnson & Johnson Vision, Menicon Co., Ltd., Nidek Co. Ltd., Topcon Corporation, Tylock-George Eye Care & Laser Center, and Ziemer Ophthalmic Systems AG.

Market Segmentation & Coverage

This research report categorizes the Myopia & Presbyopia Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Treatment, market is studied across Contact Lenses, Medication, Prescription Lenses, and Surgery.
• Based on Indication, market is studied across Myopia and Presbyopia.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Prevalence of Vision Impairment
    • 5.1.1.2. Rising Geriatric Population
    • 5.1.1.3. Minimally Invasive Alternative for Presbyopia Correction
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of Early Diagnosis and Product Recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing Market Amalgamation Activity
    • 5.1.3.2. Emerging Developments with Introduction of Advanced Lenses such as Implantable Contact Lenses
  • 5.1.4. Challenges
    • 5.1.4.1. High Cost Associated with the Treatment
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Myopia & Presbyopia Treatment Market, by Treatment

• 6.1. Introduction
• 6.2. Contact Lenses
• 6.3. Medication
• 6.4. Prescription Lenses
• 6.5. Surgery

7. Myopia & Presbyopia Treatment Market, by Indication

• 7.1. Introduction
• 7.2. Myopia
• 7.3. Presbyopia

8. Americas Myopia & Presbyopia Treatment Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Myopia & Presbyopia Treatment Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Myopia & Presbyopia Treatment Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ABB Optical Group
• 2. AbbVie Inc.
• 3. Accu-Lens Inc.
• 4. Alcon Vision LLC
• 5. Arctic Vision
• 6. Bausch & Lomb Incorporated by Bausch Health Companies Inc.
• 7. Carl Zeiss AG
• 8. CooperVision, Inc.
• 9. Essilor Group
• 10. Euclid Systems Corporation
• 11. Eyenovia, Inc.
• 12. Haag-Streit Group
• 13. Johnson & Johnson Vision
• 14. Menicon Co., Ltd.
• 15. Nidek Co. Ltd.
• 16. Topcon Corporation
• 17. Tylock-George Eye Care & Laser Center
• 18. Ziemer Ophthalmic Systems AG